Furosemide Completed Phase 2 Trials for Acute Lung Injury (ALI) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00624650Hemodynamics and Extravascular Lung Water in Acute Lung Injury